Drug Profile
ASP 7035
Alternative Names: ASP-7035Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Astellas Pharma
- Developer Astellas Pharma; Tacurion Pharma
- Class Acetamides; Small molecules; Urologics
- Mechanism of Action Vasopressin V2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Nocturia